BioSpace News Archive

The global medical waste management market was valued at over US$ 10 Bn in 2016 and is expected to expand at the CAGR of above 5% during the forecast period of 2017 to 2025.

Medical sensors are electronic devices integrated in medical devices, equipment, and probes.

The healthcare industry has witnessed severe amount of changes with automation paving the way for newer approaches characterized by efficiency.

According to Transparency Market Research’s latest report on the global digital pathology market for the historical period 2017–2018 and forecast period 2019–2027, rising awareness about digital pathology and increase in demand for advanced technology are the factors likely to boost the growth of digital pathology market.

The DNA polymerases refer to those enzymes that generate DNA molecules through assembling of nucleotides.

Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, announces that it has allotted and issued 88,580 ordinary shares of 3 pence each credited as fully paid in respect of the exercise of 88,580 warrants at a price of 93 pence share, yielding £82,379 in cash proceeds for the Company.

Getinge announces its intention to become a CO₂neutral company by 2025. The target will be reached by a stepwise approach in several areas and supports the company’s objective to contribute to a sustainable health care environmentally as well as socially.

Protara Therapeutics, Inc. announced the appointment of Barry P. Flannelly, Pharm.D, to its Board of Directors. Dr. Flannelly, who currently serves as Executive Vice President, General Manager, North America, at Incyte, brings to Protara over 20 years of commercial and business development leadership experience across numerous leading pharmaceutical and biotech companies.

Moog Inc.

Lantern Pharma (NASDAQ: LTRN) , a clinical stage biotechnology company using its proprietary RADR® artificial intelligence (“A.I.”) platform to improve drug discovery and development and, identify patients who will benefit from its portfolio of targeted oncology therapeutics, announced today that it will host a conference call and live webca